Who has been buying Metabiomed stock?

4 distinct insiders have filed 53 disclosed insider purchases in Metabiomed (059210), most recently on 2026-07-14. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Metabiomed have?

Metabiomed has 53 buy-side and 0 sell-side disclosures on record, covering ₩563M ($391K) in total reported value, spanning 2024-06-27 to 2026-07-14.

Where does StockDrifts get Metabiomed insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Metabiomed 059210

Company

메타바이오메드Metabiomed

Insiders

Buys

Total Value

₩563M ($391K)

Avg Return

+13.29%

Last Filing

2026-07-14

Metabiomed (059210) has 53 disclosed insider purchases and 0 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩563M ($391K) in reported transaction value. The earliest filing StockDrifts holds for Metabiomed is dated 2024-06-27; the most recent is 2026-07-14. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +13.29%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-07-14	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	500	₩3,705	+6.2%	₩2M ($1K)
2026-07-02	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	500	₩3,695	+6.5%	₩2M ($1K)
2026-06-19	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	600	₩3,810	+3.3%	₩2M ($2K)
2026-06-12	BUY	장외매수	오지수 Oh Ji Soo	president	228.0K	₩3,795	-1.4%	₩865M ($601K)
2026-06-10	BUY	Market Buy	오지수 Oh Ji Soo	president	500	₩3,530	+6.0%	₩2M ($1K)
2026-06-10	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	200	₩3,530	+6.0%	₩706K ($490)
2026-06-09	BUY	Market Buy	오지수 Oh Ji Soo	president	900	₩3,540	+5.7%	₩3M ($2K)
2026-06-09	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	500	₩3,540	+5.7%	₩2M ($1K)
2026-06-08	BUY	Market Buy	오지수 Oh Ji Soo	president	1.0K	₩3,385	+10.5%	₩3M ($2K)
2026-06-04	BUY	Market Buy	오지수 Oh Ji Soo	president	867	₩3,635	+2.9%	₩3M ($2K)
2026-06-02	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	300	₩3,620	-0.4%	₩1M ($754)
2026-06-02	BUY	Market Buy	오지수 Oh Ji Soo	president	3.0K	₩3,620	+3.3%	₩11M ($8K)
2026-05-20	BUY	Market Buy	오지수 Oh Ji Soo	president	400	-	-	-
2026-05-18	BUY	Market Buy	오지수 Oh Ji Soo	president	1.4K	-	-	-
2026-05-15	BUY	Market Buy	오지수 Oh Ji Soo	president	800	-	-	-
2026-05-12	BUY	Market Buy	오지수 Oh Ji Soo	president	300	-	-	-
2026-05-08	BUY	Market Buy	오지수 Oh Ji Soo	president	500	-	-	-
2026-05-06	BUY	Market Buy	오지수 Oh Ji Soo	president	1.8K	-	-	-
2026-04-30	BUY	Market Buy	오지수 Oh Ji Soo	president	500	-	-	-
2026-04-22	BUY	Market Buy	오지수 Oh Ji Soo	president	633	₩4,495	+3.2%	₩3M ($2K)
2026-04-22	BUY	Market Buy	오지수 Oh Ji Soo	president	633	₩4,495	+1.3%	₩3M ($2K)
2026-04-21	BUY	Market Buy	오지수 Oh Ji Soo	president	300	₩4,505	+1.1%	₩1M ($939)
2026-04-21	BUY	Market Buy	오지수 Oh Ji Soo	president	300	₩4,505	+3.0%	₩1M ($939)
2026-04-20	BUY	Market Buy	오지수 Oh Ji Soo	president	700	₩4,620	+0.4%	₩3M ($2K)
2026-04-20	BUY	Market Buy	오지수 Oh Ji Soo	president	700	₩4,620	-1.4%	₩3M ($2K)
2026-04-17	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	200	₩4,680	-2.7%	₩936K ($650)
2026-04-17	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	200	₩4,680	-0.8%	₩936K ($650)
2026-04-03	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	200	₩4,225	+9.8%	₩845K ($587)
2026-04-03	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	200	₩4,225	+7.8%	₩845K ($587)
2026-03-05	BUY	Market Buy	오지수 Oh Ji Soo	president	1.1K	₩4,600	+0.9%	₩5M ($4K)
2026-03-05	BUY	Market Buy	오지수 Oh Ji Soo	president	1.1K	₩4,600	-1.0%	₩5M ($4K)
2026-03-04	BUY	Market Buy	오지수 Oh Ji Soo	president	60	₩4,385	+3.9%	₩263K ($183)
2026-03-04	BUY	Market Buy	오지수 Oh Ji Soo	president	60	₩4,385	+5.8%	₩263K ($183)
2026-01-30	BUY	Market Buy	서용철 Seo Yong-cheol	Managing Director	1.3K	₩4,890	+6.8%	₩6M ($4K)
2026-01-29	BUY	Market Buy	윤종필 Jongpil Yoon	Managing Director	2.0K	₩4,945	+5.6%	₩10M ($7K)
2026-01-29	BUY	Market Buy	이승환 Seunghwan Lee	moving	1.3K	₩4,945	+5.6%	₩6M ($4K)
2026-01-21	BUY	Market Buy	오지수 Oh Ji Soo	president	2.8K	₩4,560	+14.5%	₩13M ($9K)
2026-01-16	BUY	Market Buy	오지수 Oh Ji Soo	president	673	₩4,630	+12.7%	₩3M ($2K)
2026-01-15	BUY	Market Buy	오지수 Oh Ji Soo	president	17.9K	₩4,630	+12.7%	₩83M ($57K)
2026-01-14	BUY	Market Buy	오지수 Oh Ji Soo	president	4.0K	₩4,610	+13.2%	₩18M ($13K)
2025-11-24	BUY	Market Buy	오지수 Oh Ji Soo	president	3.9K	₩4,955	+5.3%	₩19M ($14K)
2025-11-19	BUY	Market Buy	오지수 Oh Ji Soo	president	12.3K	₩5,340	-2.3%	₩66M ($46K)
2025-07-08	BUY	전환사채의권리행사	오지수 Oh Ji Soo	president	16.3K	₩5,280	-1.1%	₩86M ($60K)
2025-06-24	SELL	전환등	오지수 Oh Ji Soo	president	-16.3K	₩5,630	+7.3%	₩92M ($64K)
2025-06-11	BUY	CB인수	오지수 Oh Ji Soo	president	16.3K	₩5,640	-7.5%	₩92M ($64K)
2025-02-05	BUY	Market Buy	오지수 Oh Ji Soo	president	630	₩4,045	+29.1%	₩3M ($2K)
2024-12-11	BUY	Market Buy	오지수 Oh Ji Soo	president	4.0K	₩3,595	+45.2%	₩14M ($10K)
2024-12-10	BUY	Market Buy	오지수 Oh Ji Soo	president	7.1K	₩3,490	+49.6%	₩25M ($17K)
2024-11-25	BUY	Market Buy	오지수 Oh Ji Soo	president	3.1K	₩3,660	+42.6%	₩11M ($8K)
2024-11-22	BUY	Market Buy	오지수 Oh Ji Soo	president	2.0K	₩3,550	+47.0%	₩7M ($5K)

Showing the 50 most recent of 57 filings.

Frequently asked questions

Who has been buying Metabiomed stock?: 4 distinct insiders have filed 53 disclosed insider purchases in Metabiomed (059210), most recently on 2026-07-14. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Metabiomed have?: Metabiomed has 53 buy-side and 0 sell-side disclosures on record, covering ₩563M ($391K) in total reported value, spanning 2024-06-27 to 2026-07-14.
Where does StockDrifts get Metabiomed insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Metabiomed. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.